Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding CollPlant Biotechnologies Ltd changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of CLGN: Q1 2023 compared with Q2 2023
MeasureQ1 2023Of which not filed for Q2 2023Q2 2023Change
Holders181170
Shares1.55M463.9K1.53M+447.8K (+41.3%)
Value$10.9M$3.26M$12.5M+$4.86M (+63.8%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to CLGN in Q2 2023
InstitutionSharesValue% of portfolio
Pinnacle Associates Ltd484,653$3.95M0.07%
FNY Investment Advisers, LLC1,539$12.0K0.02%

Sold out (2)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of CLGN in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Simon Quick Advisors, LLC13,202$92.7K
Shay Capital LLC10,000$70.2K

Not filed for Q2 2023 yet (1)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CLGN in Q1 2023 that haven't filed for Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Investment Management of Virginia LLC463,899$3.26M